A former pharmaceutical executive traded on nonpublic information about an antipsychotic drug’s development, avoiding $1.3 ...

Demos, a medical doctor who was the Vice President of Drug Safety and Pharmacovigilance and member of the drug label team at ...

George Demos, 64, formerly of Acadia Pharmaceuticals Inc., admitted selling more than 60,000 company shares just before news broke regarding an issue with one of the company's products ...

Insiders have been trading these 5 stocks: (($ACAD)), (($EPR)), (($APLE)), (($KTOS)) and (($TSE:EFR)). Here is a breakdown of ...

VP at Acadia Pharmaceuticals, pled guilty to insider trading, avoiding a $1.3M loss by illicitly selling shares ahead of a ...

On Wednesday, state officials joined local leaders and private sector partners to celebrate the groundbreaking of Pacific ...

The former vice president of Acadia Pharmaceuticals Inc., headquartered in Sorrento Valley, pleaded guilty Friday to insider trading.

The former vice president of a Carmel Valley pharmaceutical company pleaded guilty Friday to a federal securities fraud count ...

Insider trading activity involves company insiders ... their confidence in the company's future performance. At Kiniksa Pharmaceuticals International PLC, recent insider activity has drawn ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Acadia Pharmaceuticals Inc. (ACAD ... In the final minutes of trading on Wednesday, shares hit $19, a decrease of 27% in the last 12 months.